Table 2.
Treatments | CON | NC | AB1 | AB2 | PB1 | PB2 | PB3 | SEM | P |
---|---|---|---|---|---|---|---|---|---|
BW, g | |||||||||
Initial | 488 | 493 | 471 | 492 | 513 | 496 | 492 | 10.0 | 0.247 |
Day 21 | 827 | 845 | 875 | 888 | 842 | 873 | 885 | 14.2 | 0.063 |
Day 28 | 1,175 | 1,008 | 1,047 | 1,079 | 1,059 | 1,058 | 1,053 | 28.5 | 0.038 |
BWG, g | |||||||||
Day 15 to 21 | 345c | 356b,c | 402a | 395a | 366a,b | 391a | 384a,b | 11.6 | 0.032 |
Day 22 to 28 | 346a | 169c | 177b,c | 188b,c | 202b,c | 205b | 182b,c | 11.6 | 0.001 |
Overall | 692a | 493c | 539b,c | 587b | 534b,c | 580b | 545b,c | 21.9 | 0.001 |
FI, g | |||||||||
Day 15 to 21 | 606 | 673 | 596 | 568 | 607 | 584 | 667 | 46.8 | 0.628 |
Day 22 to 28 | 702 | 634 | 574 | 611 | 637 | 630 | 608 | 27.3 | 0.138 |
Overall | 1,307 | 1,306 | 1,170 | 1,180 | 1,244 | 1,214 | 1,275 | 68.1 | 0.659 |
FE | |||||||||
Day 15 to 21 | 0.569 | 0.546 | 0.690 | 0.696 | 0.604 | 0.673 | 0.583 | 0.05 | 0.244 |
Day 22 to 28 | 0.494a | 0.267c | 0.309b,c | 0.311b,c | 0.318b | 0.325b,c | 0.300b,c | 0.02 | 0.001 |
Overall | 0.529 | 0.387 | 0.468 | 0.500 | 0.430 | 0.479 | 0.429 | 0.03 | 0.140 |
a–cMeans in the same row with different superscripts differ (P < 0.05).
The dose of B. subtilis strain in treatment was a total of at 1.5 × 105 CFU/g feed. For PB3 (2-strain combination), each strain composed 50% of the total CFU count (each strain represents 7.5 × 104 CFU/g feed). All chickens except those fed CON were infected by oral gavage at day 21 with 1.0 × 104 oocysts/bird of E. maxima.
Abberviations: AB1, diet supplemented with virginiamycin at 20 g/ton (22 ppm); AB2, diet supplemented with BMD at 50 g/ton (55 ppm); BW, body weight; BWG, body weight gain; CON, basal diet; FE, feed efficiency; FI, feed intake; NC, basal diet; PB1, diet supplemented with B. subtilis 1781; PB2, diet supplemented with B. subtilis 747; PB3: diet supplemented with B. subtilis 1781 + 747; P: P value; SEM: standard error of the mean.